Prevalence and genotype distribution of human papillomavirus in Zhengzhou, China, in 2016

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

New England Journal of Medicine · 2007 · 2.1K citations · Full text

Medicine, Oncology, Preventive Medicine +17

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Jorma Paavonen, Paulo Naud, Jorge Salmerón et al. · The Lancet · 2009 · 1.7K citations

Medicine, Gynecology, Oncology +17

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

Gloria Y. F. Ho, Robert D. Burk, S. Klein et al. · JNCI Journal of the National Cancer Institute · 1995 · 818 citations

Medicine, Obstetrics, Pathology +17

[Report of cancer epidemiology in China, 2015].

Rongshou Zheng, Kexin Sun, Siwei Zhang et al. · PubMed · 2019 · 673 citations

Medicine, Oncology, Population Health Sciences +16

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Warner K. Huh, Elmar A. Joura, Anna R. Giuliano et al. · The Lancet · 2017 · 459 citations · Full text

Veterinary Medicine, Immunology, Oncology +16